Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRDX - SurModics - Biotech IPO -- Ignore unavailable to you. Want to Upgrade?

To: Will Preska who wrote (5)	4/30/1998 8:55:00 AM
From: Donald carlson	Respond to of 84

Will, The 30% I referred to was an initial SWAG for yearly revenue. Longer term I would expect them to continue to do well. Kennards (on first call) had an initial projection on earnings of 14 cents 98, 24 in 99. I noticed they have updated to 17 cents for 98 and have not adjusted 99. Looks like they are talking a conservative path. Margins should increase rapidly as revenue overcomes fixed costs. I expect to hold SRDX long term unless the price gets out of line. Regards Don